[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352496-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352496-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","decoding-the-role-of-rpl38-in-lung-adenocarcinoma-a-multi-omics-approach","Decoding the role of RPL38 in lung adenocarcinoma - a multi-omics approach","","Ribosomal Protein L38 (RPL38) function in lung adenocarcinoma (LUAD) and its clinical relevance remain incompletely defined. The study applies machine learning to TCGA data to derive a three-gene RPL-based prognostic signature and integrates multi-omics analyses, including pan-cancer cohorts and spatial transcriptomics, to assess expression, outcome, and immunosuppressive tumor microenvironment features. Functional assays and xenografts show that RPL38 ablation suppresses LUAD proliferation, migration, and tumor growth, supporting therapeutic targeting.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/decoding-the-role-of-rpl38-in-lung-adenocarcinoma-a-multi-omics-approach/352496/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/decoding-the-role-of-rpl38-in-lung-adenocarcinoma-a-multi-omics-approach/352496.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were key RPL genes and the risk model constructed?","Question",{"text":63,"@type":64},"Machine learning was applied to TCGA data to identify pivotal RPL genes and build a predictive risk model.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What does the study report about patient prognosis and risk groups?",{"text":68,"@type":64},"A three-gene RPL-based prognostic signature was established; high-risk patients showed shorter survival and increased immunosuppressive characteristics.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports the role of RPL38 in LUAD?",{"text":72,"@type":64},"RPL38 was upregulated across multiple cancers and linked to unfavorable outcomes, with immunohistochemical and spatial transcriptomic analyses confirming aberrant LUAD expression and association with an immunosuppressive tumor microenvironment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352496,1790501100,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","TYPE Original Research PUBLISHED 12 February 2026 DOI 10.3389/fimmu.2026.1778481  \nOPEN ACCESS  \nEDITED BY  \nYunfei Liu,  \nCentral South University, China  \nREVIEWED BY  \nSirui Fu,  \nZhuhai People’s Hospital, China Xiao Zheng,  \nGeorgia Institute of Technology, United States  \n*CORRESPONDENCE  \nLu Zhang  \n [luzhang_524@aliyun.com](luzhang_524@aliyun.com);  \n [luzhang_cns@cqu.edu.cn](luzhang_cns@cqu.edu.cn)[ ](luzhang_cns@cqu.edu.cn)Liang Yu  \n[yu_liang@cqu.edu.cn](yu_liang@cqu.edu.cn)[ ](yu_liang@cqu.edu.cn)Chenguo Yao  \n[yaochenguo@cqu.edu.cn](yaochenguo@cqu.edu.cn)[ ](yaochenguo@cqu.edu.cn)Zhiqiang Wang  \n[wangzhiqiang@cqu.edu.cn](wangzhiqiang@cqu.edu.cn)[ ](wangzhiqiang@cqu.edu.cn)RECEIVED 31 December 2025 REVISED 28 January 2026 ACCEPTED 28 January 2026 PUBLISHED 12 February 2026  \nCITATION  \nZhang L, Teng F, Wang Y, Chen Y, Liu Q, Dai F, Yu L, Yao C and Wang Z (2026)  \nDecoding the role of RPL38 in lung adenocarcinoma: a multi-omics approach.  \nFront. Immunol. 17:1778481 .  \ndoi: 10.3389/fimmu.2026.1778481  \nCOPYRIGHT  \n© 2026 Zhang, Teng, Wang, Chen, Liu, Dai, Yu, Yao and Wang. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDecoding the role of RPL38 in lung adenocarcinoma:  \na multi-omics approach  \nLu Zhang 1,2,3*, Fei Teng 1,2, Yuan Wang 1,2, Yang Chen 1,2, Qiuxia Liu 1,2, Fengsheng Dai 2, Liang Yu 3*,  \nChenguo Yao 3* and Zhiqiang Wang 1,2*  \n1Center of Thoracic Cancer, Chongqing University Caner Hospital, Chongqing, China, 2Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing, China, 3The State Key Laboratory of Power Transmission Equipment and System Security and New Technology, School of Electrical Engineering, Chongqing University, Chongqing, China  \nIntroduction: Members of the Ribosomal Protein L (RPL) family are involved in diverse biological processes and cancer biology, yet their precise functions and clinical implications in lung adenocarcinoma (LUAD) remain incompletely understood. Methods: Machine learning was applied to The Cancer Genome Atlas (TCGA) data to identify pivotal RPL genes and construct a predictive risk model. Multi-omics analyses—including pan-cancer cohorts and spatial transcriptomics—were integrated to evaluate the expression and prognostic signiﬁcance of Ribosomal Protein L38 (RPL38) . Functional impacts were examined using CCK‑8, colony formation, wound healing, Transwell assays, and subcutaneous xenograft models. Results: A three‑gene RPL‑based prognostic signature was established from the TCGA‑LUAD cohort. High‑risk patients exhibited shorter survival and increased immunosuppressive characteristics. RPL38 was upregulated in multiple cancersand associated with unfavorable outcomes. Immunohistochemical and spatial transcriptomic analyses conﬁrmed its aberrant expression in LUAD and linked it to an immunosuppressive tumor microenvironment. Genetic ablation of RPL38 signiﬁcantly inhibited LUAD cell proliferation and migration in vitro, and impaired xenograft tumor growth in vivo.  \nConclusions: RPL38 plays a tumor‑promoting role in LUAD. This study clariﬁes the contribution of RPL38 to LUAD development, provides new insights into its pathogenesis, and suggests a rationale for therapeutic targeting of RPL38 in LUAD treatment.  \nKEYWORDS  \nlung adenocarcinoma, multi-omics data, progression, RPL38, tumor microenvironment, tumor immune  \n1 Introduction  \nAs the most common histologic subtype of non-small cell lung cancer (NSCLC), lung adenocarcinoma (LUAD) is a leading cause of global cancer mortality (1, 2) . Diagnostic outcomes have improved with the adopt","cbCaiegctoiLF0Kr","https://ap.wps.com/l/cbCaiegctoiLF0Kr","pdf",25445054,16,"English","# Introduction\n# Methods\n# Results\n# Conclusions","[{\"question\":\"How were key RPL genes and the risk model constructed?\",\"answer\":\"Machine learning was applied to TCGA data to identify pivotal RPL genes and build a predictive risk model.\"},{\"question\":\"What does the study report about patient prognosis and risk groups?\",\"answer\":\"A three-gene RPL-based prognostic signature was established; high-risk patients showed shorter survival and increased immunosuppressive characteristics.\"},{\"question\":\"What evidence supports the role of RPL38 in LUAD?\",\"answer\":\"RPL38 was upregulated across multiple cancers and linked to unfavorable outcomes, with immunohistochemical and spatial transcriptomic analyses confirming aberrant LUAD expression and association with an immunosuppressive tumor microenvironment.\"}]","Decoding the role of RPL38 in lung adenocarcinoma - a multi-omics approach | PDF",1790099935,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c58cf0fff261a8e9cfa33e0da450ff0.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3730e9f2218b434013f38b3689d96f35.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ef3f29afe009466b08cc6ee51d6865d.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da989f644e8eaaad71cd369a7f654572.webp",980,1385]